e-64-d (Peptide Institute)
Structured Review
E 64 D, supplied by Peptide Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e-64-d/e64d/pm38643548-63-0-2
Average 90 stars, based on 1 article reviews
Images
Related Articles
Concentration Assay:Article Title: Hyperosmotic Stress Induces Unconventional Autophagy Independent of the Ulk1 Complex Article Snippet: Chemicals 297 used in this study; Bafilomycin A1 (final 100 nM, Merck Millipore), Article Title: Unveiling the intra-tumor fate of trastuzumab deruxtecan in a xenograft model to support its mechanism of action. Article Snippet: Trastuzumab deruxtecan (T-DXd) is an antibody–drug conjugate used for cancer treatment comprising an antihuman epidermal growth factor receptor type 2 (HER2) antibody and the topoisomerase I inhibitor DXd.. The present study investigated the intratumor fate of T-DXd.. Fluorescence-labeled T-DXd was found to accumulate in tumors of HER2-positive tumor xenograft mice and was observed to be distributed within lysosomes of in vitro tumor cells in accordance with their HER2 expression. Article Title: The Microbiota Protects against Ischemia/Reperfusion-Induced Intestinal Injury through Nucleotide-Binding Oligomerization Domain-Containing Protein 2 (NOD2) Signaling Article Snippet: Cells were treated with 10 μg/mL pepstatin A (MP Pharmaceuticals, Santa Ana, CA) and 10 μg/mL Article Title: Regulatory effects of the L-lysine metabolites, L-2-aminoadipic acid and L-pipecolic acid, on protein turnover in C2C12 myotubes. Article Snippet: E-64-d and Article Title: Basal autophagy prevents autoactivation or enhancement of inflammatory signals by targeting monomeric MyD88 Article Snippet: Pepstatin A, E-64-d and Article Title: Involvement of Lamin B1 Reduction in Accelerated Cellular Senescence during Chronic Obstructive Pulmonary Disease Pathogenesis. Article Snippet: MG-132 (BMLP102; Enzo Life Sciences), Torin1 (no. 4247; Tocris Bioscience), bafilomycin A1 (BafA1) from Streptomyces griseus (no. B1793; Sigma-Aldrich), Hoechst 33258 (no. B2883; Sigma-Aldrich), MitoSOX Red (no. M36008; Molecular Probes Life Technologies), Article Title: Hyperosmotic Stress Induces Unconventional Autophagy Independent of the Ulk1 Complex Article Snippet: The chemicals used in this study were bafilomycin A1 (final concentration, 100 nM; Merck Millipore), Article Title: The cyclin-dependent kinase 4/6 inhibitor, abemaciclib, exerts dose-dependent cytostatic and cytocidal effects and induces autophagy in multiple myeloma cells. Article Snippet: The D-type cyclin (CCND)-cyclin-dependent kinase 4/6 (CDK4/6) complex has been implicated in multiple myeloma development.. We investigated the biological activity of CDK4/6 inhibitor abemaciclib on cell growth and survival in three myeloma cell lines, KMS-12-PE, RPMI 8226, and IM-9.. Abemaciclib inhibited myeloma cell growth in a dose-dependent manner in all cell lines, with significant differences seen at a concentration of 320 nM. Control:Article Title: Hyperosmotic Stress Induces Unconventional Autophagy Independent of the Ulk1 Complex Article Snippet: Chemicals 297 used in this study; Bafilomycin A1 (final 100 nM, Merck Millipore), Article Title: Unveiling the intra-tumor fate of trastuzumab deruxtecan in a xenograft model to support its mechanism of action. Article Snippet: Trastuzumab deruxtecan (T-DXd) is an antibody–drug conjugate used for cancer treatment comprising an antihuman epidermal growth factor receptor type 2 (HER2) antibody and the topoisomerase I inhibitor DXd.. The present study investigated the intratumor fate of T-DXd.. Fluorescence-labeled T-DXd was found to accumulate in tumors of HER2-positive tumor xenograft mice and was observed to be distributed within lysosomes of in vitro tumor cells in accordance with their HER2 expression. Article Title: The Microbiota Protects against Ischemia/Reperfusion-Induced Intestinal Injury through Nucleotide-Binding Oligomerization Domain-Containing Protein 2 (NOD2) Signaling Article Snippet: Cells were treated with 10 μg/mL pepstatin A (MP Pharmaceuticals, Santa Ana, CA) and 10 μg/mL Article Title: Regulatory effects of the L-lysine metabolites, L-2-aminoadipic acid and L-pipecolic acid, on protein turnover in C2C12 myotubes. Article Snippet: E-64-d and Article Title: Basal autophagy prevents autoactivation or enhancement of inflammatory signals by targeting monomeric MyD88 Article Snippet: Pepstatin A, E-64-d and Article Title: Involvement of Lamin B1 Reduction in Accelerated Cellular Senescence during Chronic Obstructive Pulmonary Disease Pathogenesis. Article Snippet: MG-132 (BMLP102; Enzo Life Sciences), Torin1 (no. 4247; Tocris Bioscience), bafilomycin A1 (BafA1) from Streptomyces griseus (no. B1793; Sigma-Aldrich), Hoechst 33258 (no. B2883; Sigma-Aldrich), MitoSOX Red (no. M36008; Molecular Probes Life Technologies), Article Title: Hyperosmotic Stress Induces Unconventional Autophagy Independent of the Ulk1 Complex Article Snippet: The chemicals used in this study were bafilomycin A1 (final concentration, 100 nM; Merck Millipore), Article Title: The cyclin-dependent kinase 4/6 inhibitor, abemaciclib, exerts dose-dependent cytostatic and cytocidal effects and induces autophagy in multiple myeloma cells. Article Snippet: The D-type cyclin (CCND)-cyclin-dependent kinase 4/6 (CDK4/6) complex has been implicated in multiple myeloma development.. We investigated the biological activity of CDK4/6 inhibitor abemaciclib on cell growth and survival in three myeloma cell lines, KMS-12-PE, RPMI 8226, and IM-9.. Abemaciclib inhibited myeloma cell growth in a dose-dependent manner in all cell lines, with significant differences seen at a concentration of 320 nM. |
